- Clinical Trials
- January 2024
- 60 Pages
Global
From €1421EUR$1,500USD£1,200GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1421EUR$1,500USD£1,200GBP
- Report
- June 2023
- 159 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2606EUR$2,750USD£2,199GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- March 2022
- 96 Pages
Global
From €7107EUR$7,500USD£5,998GBP
- Report
- February 2024
- 180 Pages
Global
From €4709EUR$4,969USD£3,974GBP
- Report
- October 2023
- 181 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- April 2023
- 110 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- November 2023
- 185 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 181 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- August 2022
- 70 Pages
Africa, Middle East
From €1421EUR$1,500USD£1,200GBP
- Drug Pipelines
- October 2020
- 62 Pages
Global
From €3317EUR$3,500USD£2,799GBP
- Report
- February 2024
- 23 Pages
Global
€16251EUR$17,150USD£13,715GBP
- Report
- October 2022
- 41 Pages
Global
From €3317EUR$3,500USD£2,799GBP
- Report
- May 2022
- 35 Pages
Global
From €3317EUR$3,500USD£2,799GBP
- Report
- November 2021
- 844 Pages
Global
From €4738EUR$5,000USD£3,999GBP
- Report
- September 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,123GBP
The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain.
The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more
